Company Overview
- Headquarters
- 200 Quebec St 205, Denver CO
- Website
- rheumagen.com
- Employees
- 6
- Founded in
- 2019
- Industry
- BioTech/Drugs
Financials & Stats
Revenue
$3B
Who is RheumaGen
RheumaGen is a biotechnology company based in Denver, Colorado. The company is a small business with four employees and generated $2.5 million in revenue. RheumaGen is focused on developing a revolutionary gene editing treatment aimed at curing Rheumatoid Arthritis. Their innovative approach holds the potential to transform the lives of millions affected by this chronic autoimmune disease. RheumaGen distinguishes itself through its cutting-edge research and development in the field of gene editing. The company's commitment to scientific excellence and its dedication to finding a cure for Rheumatoid Arthritis set it apart in the biotechnology industry. For more information about RheumaGen and its groundbreaking research, please visit their website at rheumagen.com.
RheumaGen Industry Tags
Companies Similar to RheumaGen
Analyze industry trends and opportunities by examining competitors and companies comparable to RheumaGen, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | Arvada, CO | |||
| 3M | 6 | Star Valley Ranch, WY | ||
| 3M | 4 | Ann Arbor, MI | 2006 | |
| 3M | 3 | San Diego, CA | ||
| 3M | 3 | New York, NY |